ValiRx (LON:VAL) Stock Price Passes Below Two Hundred Day Moving Average of $13.60

ValiRx plc (LON:VALGet Rating) shares passed below its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of GBX 13.60 ($0.17) and traded as low as GBX 9.25 ($0.11). ValiRx shares last traded at GBX 9.38 ($0.11), with a volume of 152,649 shares.

ValiRx Stock Performance

The firm’s 50 day moving average is GBX 10.70 and its two-hundred day moving average is GBX 13.60. The company has a debt-to-equity ratio of 1.77, a quick ratio of 1.27 and a current ratio of 1.27. The stock has a market capitalization of ¬£9.59 million, a PE ratio of -312.50 and a beta of 1.55.

About ValiRx

(Get Rating)

ValiRx plc, a biopharmaceutical company, engages in the development of oncology therapeutics and companion diagnostics in the United Kingdom. The company's lead drug candidates include VAL201, a small molecule that has completed Phase I/II trials for the treatment of prostate cancer and other hormone associated solid tumours comprising breast and ovarian cancer; and VAL401, a reformulation of anti-psychotic drug risperidone, which has completed Phase II clinical trial for the treatment of non-small cell lung cancer.

Read More

Receive News & Ratings for ValiRx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ValiRx and related companies with MarketBeat.com's FREE daily email newsletter.